Health Coalition

What Health Coalition does

Health Coalition LLC (operating as Health Coalition, Inc. and abbreviated HCI) is a privately held, NABP-accredited wholesale drug distributor headquartered in Doral, Florida. Founded in 1988, the company specializes in distributing specialty pharmaceuticals — including injectable therapies (e.g., Azacitidine, Decitabine, Docetaxel, Fosaprepitant, Palonosetron, Fulvestrant), oral specialty therapies (oncology, hematology, antineoplastics, immunosuppressives, antifungals, NSAIDs, DMARDs), and plasma derivatives including IVIG — to physicians, medical offices, hospitals, pharmacies, specialty pharmacies, and home health care companies across the United States. Health Coalition pioneered 24-hour service in the specialty pharmaceutical distribution industry in 1990 and remains in continuous operation more than three decades later.

The company monetizes through transactional wholesale product sales on quote-based pricing to healthcare providers, with no publicly disclosed list pricing. Its go-to-market is enterprise field sales conducted as direct distribution relationships, with the company explicitly positioning itself as 'an extension of the manufacturers we represent and the customers we serve.' Differentiated operational capabilities include 24/7 emergency on-call distribution with a 10-minute response commitment, multi-million dollar inventory depth, climate-controlled and validated refrigeration for cold-chain products, just-in-time order fulfillment, and real-time product tracking that supports rapid reaction to manufacturer recalls and shortages. A cloud-based DQSA/DSCSA compliance portal exposes real-time inventory levels, sales distribution data, and trend analytical tools to upstream and downstream trading partners.

Health Coalition is privately held with no disclosed venture capital, private equity, or external funding rounds, and ownership structure is not publicly disclosed. The company states a headcount of 51–100 employees. Geographic scope is United States only, with marketing conducted primarily through the company website and an email newsletter subscription list; no mobile app, public API, or e-commerce storefront is offered. AI/ML capabilities are not disclosed in available materials. The company holds NABP accreditation and is described as fully insured and nationally licensed.

Name

Health Coalition

Legal name

Health Coalition LLC

Website

https://healthcoalition.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

51–100 employees

Short description

Health Coalition LLC is a privately held, NABP-accredited U.S. wholesale drug distributor founded in 1988, specializing in injectable, oral, and plasma-derivative specialty pharmaceuticals for physicians, hospitals, pharmacies, specialty pharmacies, and home health providers, supported by 24/7 emergency distribution and a cloud-based DSCSA compliance platform.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYCRAOAHAD

Specialty Pharmacy & Biologics Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

SECONDARYHLAIAJAD

Hospital & Health-System Pharmaceutical Distributors

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYHLACAKAI

Medication Inventory, Procurement & Supply Chain (Pharmacy)

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

• Specialty pharmaceutical distribution
• Wholesale drug distribution
• Injectable therapies
• Plasma derivatives
• Pharmaceutical compliance

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Specialty Pharmaceutical Distribution: Wholesale distribution of specialty pharmaceuticals including injectable therapies, oral therapies, and plasma derivatives to healthcare providers. Revenue generated through product sales to physicians, medical offices, hospitals, pharmacies, specialty pharmacies, and home health care companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Health Coalition is a nationally licensed wholesale drug distributor that distributes specialty pharmaceuticals including injectable therapies, oral therapies, and plasma derivatives to healthcare providers. The company offers 24/7 emergency on-call distribution with a 10-minute response time, just-in-time order fulfillment, multi-million dollar climate-controlled inventory, and a cloud-based DQSA/DSCSA compliance platform serving both upstream and downstream trading partners.

Product overview

Health Coalition, Inc. is a nationally licensed wholesale drug distributor and NABP-accredited specialty pharmaceutical distributor established in 1988, offering a portfolio of injectable therapies (including Azacitidine, Decitabine, Docetaxel, Fosaprepitant, Palonosetron), oral therapies, and plasma derivatives. The company operates a cloud-based DQSA/DSCSA compliance platform and provides 24/7 emergency on-call pharmaceutical distribution services. Their core product lines include chemotherapy drugs, antiemetics, and specialty medications for treating cancer, immune disorders, and other chronic conditions, distributed to physicians, medical offices, hospitals, pharmacies, specialty pharmacies, and home health care companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Azacitidine (Vidaza) Chemotherapy drug (demethylation agent/hypomethylating agent) used to treat Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). Blocks DNA methylation and prevents cancer cells from growing and dividing.
• Decitabine (Dacogen) Antimetabolite and demethylation agent chemotherapy medication for MDS and AML. Interferes with DNA synthesis by killing rapidly dividing cancer cells and decreases methylation to activate tumor suppressor genes.
• Docetaxel (Taxotere) Plant alkaloid chemotherapy drug used to treat breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer, and metastatic prostate cancer.
• Fosaprepitant (Emend for Injection) NK1 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). Blocks the NK1 receptor in the brain that triggers the desire to vomit; used with other antiemetics.
• Fulvestrant (Faslodex) Estrogen receptor antagonist hormone therapy for advanced or metastatic hormone-related breast cancer in postmenopausal women. Works as an estrogen down regulator to block effects of estrogen on cancer cells.
• Ondansetron (Zofran) First-generation 5-HT3 receptor antagonist for preventing nausea and vomiting caused by chemotherapy, radiation therapy, or post-operative procedures. Blocks serotonin released by damaged cells along the gastrointestinal tract.
• Palonosetron (Aloxi) 5-HT3 receptor antagonist for preventing acute or delayed chemotherapy-induced nausea and vomiting (CINV) and post-operative nausea and vomiting (PONV). Has the longest elimination half-life in its drug class.
• Injectable Therapies Wide range of injectable therapies including antibiotics, antineoplastics, serotonin inhibitors, and steroids. Includes a full line of chemotherapies and antiemetics for acute care, specialty, homecare, infusion, and retail pharmacy settings.
• Oral Therapies Expanding portfolio of oral prescription drugs including oncology and hematology therapies, antineoplastics, immunosuppressives, antifungals, NSAIDs, and DMARDs, serving hematology, oncology, infectious diseases, neurology, urology, and rheumatology physicians.
• Plasma Derivatives Plasma derivatives including IVIG therapies used for treatment of immunodeficiency diseases, autoimmune inflammatory diseases, hemophilia, chronic lymphocytic leukemia, multiple myeloma, and other life-threatening diseases.
• 24/7 Emergency On-Call Service Emergency pharmaceutical distribution service available 24 hours a day, 7 days a week, with professionals responding to emergency situations in 10 minutes or less. Includes multi-million dollar inventory, climate-controlled refrigeration, and Same Day, Next Day, or Regular Ground delivery options.
• DQSA/DSCSA Compliance Innovations Cloud-based compliance solution incorporating compliance data and business analytical tools for both upstream and downstream trading partners. Provides real-time inventory levels, sales distribution, and trend analytical tools, along with access to DQSA/DSCSA transaction (T3) data via an online compliance portal.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• NABP (National Association of Boards of Pharmacy)coreOthersHealth Coalition is NABP accredited as a nationally licensed wholesale drug distributor, which validates their compliance with pharmaceutical distribution standards and regulatory requirements.
• Trading Partners (Upstream and Downstream)coreTechnology or IntegrationCloud-based DQSA/DSCSA compliance solution providing real-time inventory levels, sales distribution, and trend analytical tools to both upstream and downstream trading partners.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Cencora (formerly AmerisourceBergen): Cencora is one of the Big 3 U.S. pharmaceutical distributors with a dedicated specialty distribution and services division (formerly US Bioservices, ION Solutions, and PharmaLex). Directly comparable on specialty oncology/hematology distribution scale, but with far broader product and service portfolio.
• McKesson: McKesson is the largest U.S. pharmaceutical distributor and operator of the North America BioPharma Solutions specialty distribution network. Overlaps with Health Coalition on specialty pharma wholesale, but McKesson serves the full continuum including retail, hospital, and broadline channels with vastly greater scale.
• Cardinal Health: Cardinal Health is one of the Big 3 U.S. pharmaceutical wholesalers with a specialty pharmaceutical distribution arm (formerly Integrated Oncology Network and Sonexus Health). Operates in the same wholesale distribution category as Health Coalition but at substantially larger scale and with broader customer reach.

Direct peers

• Biologics by McKesson: Biologics by McKesson is McKesson's specialty oncology distribution business, providing specialty pharmaceuticals, including oncology and hematology products, to physician practices, hospitals, and specialty pharmacies. Closely comparable to Health Coalition's specialty oncology, hematology, and plasma derivative distribution offering.
• Avella Specialty Pharmacy: Avella (formerly BioPlus, now part of the Baker Family of companies / Strategic Buyer) is a specialty pharmacy distributing oncology, fertility, and other complex therapy medications to patients and providers. Directly overlapping niche specialty distribution including injectable and oral specialty products to physicians and specialty pharmacies, like Health Coalition.
• Onco360: Onco360 is an independent specialty pharmacy focused exclusively on oncology and rare disease therapies, distributing oral and injectable specialty medications to providers and patients nationwide. Comparable to Health Coalition's specialty pharma distribution focus, particularly for oncology and hematology oral/injectable products.
• Specialty Medical Products (SMP): SMP is an independent specialty distributor of pharmaceuticals including chemotherapy, biologicals, and supportive care drugs serving oncology practices and specialty pharmacies. Operates in the same specialty distribution niche as Health Coalition with overlapping product categories like antiemetics and chemotherapeutics.

Emerging players

• BioCare SD: BioCare is a specialty distributor focused on immune globulin (IVIG/SCIG), plasma-derived therapies, and other specialty biologics. Compares against Health Coalition's plasma derivatives business line, with comparable specialty provider customers but with a narrower, more biologics-focused portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/healthcoalition
• LinkedInlinkedin.com/company/health-coalition-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Coalition